English
Earnings 2026
Johnson & Johnson earnings: Dividend King tests key support
Johnson & Johnson shares face an important test ahead of Q3 earnings on 13 October 2026. Following the recent pullback, the Dividend King has reached a support area that could shape its next move. Results and guidance may provide the catalyst for a recovery—or expose the stock to further selling pressure.
At a glance
Johnson & Johnson is testing key support between $245 and $251 ahead of earnings. A successful defence could open the way for a recovery towards $265. However, the short-term rising trendline has already broken. Below support, the rising 200-day EMA becomes the next important level to watch.
Johnson & Johnson Q3 earnings: Date and expectations
| Metric | Timing or expectation |
|---|---|
| Results release | Tuesday, 13 October 2026, before the US market opens |
| Expected release time | Around 12:20 CEST, according to the earnings calendar |
| Earnings call | 14:30 CEST |
| Expected revenue | $25.37 billion |
| Expected earnings per share | $2.90 |
The company has confirmed the earnings call for 14:30 CEST. The release-time indication and consensus estimates come from the earnings-calendar snapshot dated 6 October; the precise release time remains a calendar indication. The snapshot does not specify the EPS accounting basis.
Higher full-year guidance sets the benchmark
Following Q2, Johnson & Johnson raised the midpoint of its 2026 revenue guidance to $101.1 billion and its adjusted earnings-per-share guidance midpoint to $11.68. Those higher targets provide an important benchmark for the upcoming report.
Investors will assess whether Innovative Medicine and MedTech can sustain the group’s growth. Alongside revenue and earnings, margins and full-year guidance deserve attention. Strong quarterly figures could lose some of their impact if management adopts a more cautious outlook.
Seasonality points to a historically favourable autumn window
The 25-year Seasonax study shows an average gain of 3.34% between 9 October and 18 November. Returns were positive in 20 of the 25 observations, a historical frequency of 80%. The median return was 3.36%.
This provides a favourable historical backdrop for a potential recovery. However, the pattern covers several weeks and does not predict the immediate share-price reaction to earnings.
Johnson & Johnson: 25-Year Seasonal Pattern
Analysts see longer-term upside
The supplied TipRanks snapshot contains 14 Buy ratings and four Holds, with no Sell ratings among the 18 analysts covered. The overall consensus is “Strong Buy”.
The average 12-month price target stands at $288.56, with individual targets ranging from $260 to $320. Against the snapshot’s reference price of $252.92, that represents 14.09% upside. These are longer-term targets rather than forecasts for the earnings-day reaction.
Johnson & Johnson: Analyst Ratings and 12-Month Price Targets
Technical analysis: $245–$251 support comes into focus
The summer breakout above the former resistance area around $245–$251 opened the way for further gains. Subsequent pullbacks, particularly in July, established this zone as support. Although the advance continued, repeated long upper candle wicks around the highs pointed to increasing selling pressure.
The stock broke below its short-term rising trendline in early October. Horizontal support is now back in focus: the latest daily low shown on the chart, $251.17, almost touched the zone’s upper boundary. The displayed closing price is $254.78.
Holding the $245–$251 support area could allow a recovery towards $265. A sustained move above $273 would improve the technical picture further, although the previous highs around $278–$281 would remain the next resistance area.
Below horizontal support, the rising 200-day EMA at $240.80 provides another important line of defence for the broader uptrend. A sustained break beneath it would increase the risk of a deeper correction.
The RSI shows a slight stabilisation at the right edge of the chart. However, its displayed reading of 46.35 remains below the 48.5 threshold used in this analysis. Reclaiming that level would provide additional confirmation of improving upward momentum.
Johnson & Johnson Daily Chart: $245–$251 Support in Focus
Long and short setups
| Scenario | Trigger and confirmation | Targets | Risk control |
|---|---|---|---|
| Long | $245–$251 support holds, followed by a confirmed recovery above $255. RSI above 48.5 adds confirmation | $265, followed by $273 | Below the confirmed reversal low; a sustained break below $245 undermines the scenario |
| Short | Daily close below $245, followed by a failed retest of the support area | Initially $240–$241 at the 200-day EMA | Above the retest high; a successful recovery into the zone weakens the scenario |
JNJ: Five-Year Share Price Performance
Ready to start your trading journey?
Open an IG account now
Follow us online:
